To meet the demands of our customers and the market, we have equipped ourselves with a multi-dose aseptic filling capacity. Unither offers development services and subcontracting of ophthalmic formulas for both PFMD and MDWP technologies.
One of our key facilities is Unither Laboratoire in Coutances, France, focusing on preservative-free multidose. Another major site is Unither's Butantã facility in São Paulo, Brazil, specializing in multidoses with preservative. Both locations specialize in ophthalmology. Continuous investments allow the company to manufacture ophthalmic health products across four continents: Europe, Asia, North America, and South America.
PFMD:
MDWP:
Both PFMD and MDWP fit different statuses: drugs, medical devices, OTC, cosmetics, etc., and formulation types: ophthalmic solutions and suspensions, and otology products.
As with the BFS technology, the process design strongly limits the risk of environmental contamination as the machine is:
The sites are regularly inspected by various authorities including: EMA (Europe), FDA (USA), ANVISA (Brazil), MHRA, KFDA, Russian MOH, Turkish MOH, Mexico, and other health authorities around the world.
Total capacity:
More than 100 million bottles/year
Coutances, France
São Paulo, Brazil
